Treco Douglas A Insider Trades

Insider Trading History

Track insider trading activity for Treco Douglas A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $1.25M 22,000 shares
Last Trade
Aug 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.14M 20,000 shares
$57.03
$56.95
Inozyme Pharma
Inozyme Pharma INZY
CEO & Chairman
Holding Value $0 0 shares
Last Trade
Jul 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.95M 486,979 shares
$4.00
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO & Chairman
Holding Value $0 0 shares
Last Trade
Jul 01, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$175k 43,861 shares
$4.00
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO & Chairman
Holding Value $175k 43,861 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 2,815 shares
$3.99
$4.00
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $740k 13,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$501k 13,000 shares
$38.57
$56.95
Inozyme Pharma
Inozyme Pharma INZY
CEO & Chairman
Holding Value $164k 41,046 shares
Last Trade
Apr 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.85k 8,819 shares
$0.89
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO & Chairman
Holding Value $200k 50,000 shares
Last Trade
Apr 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.8k 25,000 shares
$0.87
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO & Chairman
Holding Value $199k 49,865 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.8k 25,000 shares
$0.87
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $1.6M 400,000 shares
Last Trade
Mar 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$424k 400,000 shares
$1.06
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $89.5k 22,375 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.94k 1,710 shares
$5.23
$4.00
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $740k 13,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$703k 13,000 shares
$54.06
$56.95
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $82.7k 20,665 shares
Last Trade
Apr 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.2k 7,523 shares
$6.94
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $113k 28,188 shares
Last Trade
Apr 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$183k 25,000 shares
$7.31
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $300k 75,000 shares
Last Trade
Apr 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$183k 25,000 shares
$7.31
$4.00
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $1.2M 300,000 shares
Last Trade
Mar 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73M 300,000 shares
$5.77
$4.00
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $740k 13,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$814k 13,000 shares
$62.59
$56.95
Inozyme Pharma
Inozyme Pharma INZY
CEO
Holding Value $3.2M 800,000 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.58M 800,000 shares
$5.73
$4.00
Inozyme Pharma
Inozyme Pharma INZY
Director
Holding Value $37.5k 9,367 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41k 9,367 shares
$4.38
$4.00
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Director
Holding Value $683k 12,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72M 24,000 shares
$71.70
$56.95
Inozyme Pharma
Inozyme Pharma INZY
Director
Holding Value $37.5k 9,367 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 9,367 shares
$17.12
$4.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up